Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation

European Journal of Endocrinology

Volumn 152, Issue 4, 2005, Pages 625-634

  Neumann, Susanne ^a   Claus, Maren ^a   Paschke, Ralf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; INOSITOL PHOSPHATE; THYROTROPIN; THYROTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; GENE MUTATION; HORMONAL REGULATION; IN VIVO STUDY; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INOSITOL PHOSPHATES; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN CONFORMATION; RADIOLIGAND ASSAY; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; THYROTROPIN; TRANSFECTION;

EID: 17744366823     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01891     Document Type: Article

References (52)

1. Gudermann T, Nurnberg B & Schultz G. Receptors and G proteins as primary components of transmembrane signal transduction. Part 1. G-protein-coupled receptors: structure and function. Journal of Molecular Medicine 1995 73 51-63.
2. Nagayama Y & Rapoport B. The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Molecular Endocrinology 1992 6 145-156.
3. Segaloff DL & Ascoli M. The lutropin/choriogonadotropin receptor ... 4 years later. Endocrine Reviews 1993 14 324-347.
4. Simoni M, Gromoll J & Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocrine Reviews 1997 18 739-773.
5. Rapoport B, Chazenbalk GD, Jaume JC & McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocrine Reviews 1998 19 673-716.
6. Vassart G, Desarnaud F, Duprez L, Eggerickx D, Labbe O, Libert F, Mollereau C, Parma J, Paschke R, Tonacchera M, Vanderhaeghen P, Van Sande J, Dumont J & Parmentier M. The G protein-coupled receptor family and one of its members, the TSH receptor. Annals of the New York Academy of Sciences 1995 766 23-30.
7. Thomas D, Rozell TG, Liu X & Segaloff DL. Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1-6 are involved in hormone binding. Molecular Endocrinology 1996 10 760-768.
8. Braun T, Schofield PR & Sprengel R. Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO Journal 1991 10 1885-1890.
9. Smits G, Govaerts C, Nubourgh I, Pardo L, Vassart G & Costagliola S. Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG. Molecular Endocrinology 2002 16 722-735.
10. Sangkuhl K, Schulz A, Schultz G & Schoneberg T. Structural requirements for mutational lutropin/choriogonadotropin receptor activation. Journal of Biological Chemistry 2002 277 47748-47755.
11. Bhowmick N, Narayan P & Puett D. Identification of ionizable amino acid residues on the extracellular domain of the lutropin receptor involved in ligand binding. Endocrinology 1999 140 4558-4563.
12. Vischer HF, Granneman JC, Noordam MJ, Mosselman S & Bogerd J. Ligand selectivity of gonadotropin receptors. Role of the beta-strands of extracellular leucine-rich repeats 3 and 6 of the human luteinizing hormone receptor. Journal of Biological Chemistry 2003 278 15505-15513.
13. Song YS, Ji I, Beauchamp J, Isaacs NW & Ji TH. Hormone interactions to Leu-rich repeats in the gonadotropin receptors. II. Analysis of Leu-rich repeat 4 of human luteinizing hormone/chorionic gonadotropin receptor. Journal of Biological Chemistry 2001 276 3436-3442.
14. Seetharamaiah GS, Kurosky A, Desai RK, Dallas JS & Prabhakar BS. A recombinant extracellular domain of the thyrotropin (TSH) receptor binds TSH in the absence of membranes. Endocrinology 1994 134 549-554.
15. Shi Y, Zou M, Parhar RS & Farid NR. High-affinity binding of thyrotropin to the extracellular domain of its receptor transfected in Chinese hamster ovary cells. Thyroid 1993 3 129-133.
16. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G & Costagliola S. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Molecular Endocrinology 2002 16 736-746.
17. Zhang M, Tong KP, Fremont V, Chen J, Narayan P, Puett D, Weintraub BD & Szkudlinski MW. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinology 2000 141 3514-3517.
18. Cetani F, Tonacchera M & Vassart G. Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone/chorionic gonadotropin receptors. FEBS Letters 1996 378 27-31.
19. Van Sande J, Massart C, Costagliola S, Allgeier A, Cetani F, Vassart G & Dumont JE. Specific activation of the thyrotropin receptor by trypsin. Molecular and Cellular Endocrinology 1996 119 161-168.
20. Zhang ML, Sugawa H, Kosugi S & Mori T. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain. Biochemical and Biophysical Research Communications 1995 211 205-210.
21. Fuhrer D, Lachmund P, Nebel IT & Paschke R. The thyrotropin receptor mutation database: update 2003. Thyroid 2003 13 1123-1126.
22. Paschke R & Ludgate M. The thyrotropin receptor in thyroid diseases. New England Journal of Medicine 1997 337 1675-1681.
23. Duprez L, Parma J, Costagliola S, Hermans J, Van Sande J, Dumont JE & Vassart G. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Letters 1997 409 469-474.
24. Ho SC, Van Sande J, Lefort A, Vassart G & Costagliola S. Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology 2001 142 2760-2767.
25. Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL & Rodd C. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281→isoleucine) in the extracellular domain of the thyrotropin receptor. Journal of Clinical Investigation 1997 100 1634-1639.
26. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G, Costagliola S, Rodien P, Dumont JE & Vassart G. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. Journal of Clinical Endocrinology and Metabolism 1997 82 2695-2701.
27. Nakabayashi K, Kudo M, Kobilka B & Hsueh AJ. Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region. Journal of Biological Chemistry 2000 275 30264-30271.
28. Higuchi R. Using PCR to engineer DNA. In PCR Technology pp 61-70, pp. Ed. HA Erlich. New York: Stockton Press, 1989.
29. Libert F, Lefort A, Gerard C, Parmentier M, Perret J, Ludgate M, Dumont JE & Vassart G. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochemical and Biophysical Research Communications 1989 165 1250-1255.
30. Wonerow P, Schoneberg T, Schultz G, Gudermann T & Paschke R. Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation. Journal of Biological Chemistry 1998 273 7900-7905.
31. Berridge MJ. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochemical Journal 1983 212 849-858.
32. Wonerow P, Chey S, Fuhrer D, Holzapfel HP & Paschke R. Functional characterization of five constitutively activating thyrotrophin receptor mutations. Clinical Endocrinology 2000 53 461-468.
33. Swillens S. Interpretation of binding curves obtained with high receptor concentrations: practical aid for computer analysis. Molecular Pharmacology 1995 47 1197-1203.
34. Fuhrer D, Holzapfel HP, Wonerow P, Scherbaum WA & Paschke R. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. Journal of Clinical Endocrinology and Metabolism 1997 82 3885-3891.
35. Kosugi S, Matsuda A, Hai N, Aoki N, Sugawa H & Mori T. Aspartate-474 in the first exoplasmic loop of the thyrotropin receptor is crucial for receptor activation. FEBS Letters 1997 406 139-141.
36. Neumann S, Krause G, Chey S & Paschke R. A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation. Molecular Endocrinology 2001 15 1294-1305.
37. Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J & Vassart G. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3′,5′-monophosphate and inositol phosphate-Ca2+ cascades. Molecular Endocrinology 1995 9 725-733.
38. Tonacchera M, Agretti P, Pinchera A, Rosellini V, Perri A, Collecchi P, Vitti P & Chiovato L. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene. Journal of Clinical Endocrinology and Metabolism 2000 85 1001-1008.
39. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J & Vassart G. Somatic and germline mutations of the TSH receptor gene in thyroid diseases. Journal of Clinical Endocrinology and Metabolism 1995 80 2577-2585.
40. Haraguchi K, Saito T, Endo T & Onaya T. Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding. Life Sciences 1994 55 961-968.
41. Kaneshige M, Haraguchi K, Endo T, Anzai E & Onaya T. The functional significance of the second extracellular loop of thyrotropin receptor in thyrotropin- and thyroid stimulating antibody-dependent signal transduction. Hormone and Metabolic Research 1995 27 267-271.
42. Wonerow P, Neumann S, Gudermann T & Paschke R. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action. Journal of Molecular Medicine 2001 79 707-721.
43. Ji I & Ji TH. Receptor activation is distinct from hormone binding in intact lutropin-choriogonadotropin receptors and Asp397 is important for receptor activation. Journal of Biological Chemistry 1993 268 20851-20854.
44. Ji I & Ji TH. Differential roles of exoloop 1 of the human follicle-stimulating hormone receptor in hormone binding and receptor activation. Journal of Biological Chemistry 1995 270 15970-15973.
45. Govaerts C, Lefort A, Costagliola S, Wodak SJ, Ballesteros JA, Van Sande J, Pardo L & Vassart G. A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor. Journal of Biological Chemistry 2001 276 22991-22999.
46. Farid NR & Szkudlinski MW. Minireview: structural and functional evolution of the thyrotropin receptor. Endocrinology 2004 145 4048-4057.
47. Kaczur V, Puskas LG, Takacs M, Racz IA, Szendroi A, Toth S, Nagy Z, Szalai C, Balazs C, Falus A, Knudsen B & Farid NR. Evolution of the thyrotropin receptor: a G protein coupled receptor with an intrinsic capacity to dimerize. Molecular Genetics and Metabolism 2003 78 275-290.
48. Trultzsch B, Nebel T & Paschke R. The TSH receptor mutation database. European Journal of Endocrinology 1999 140 VII.
49. Trulzsch B, Nebel T & Paschke R. The thyrotropin receptor mutation database. Thyroid 1999 9 521-522.
50. Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G & Parma J. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. Journal of Clinical Endocrinology and Metabolism 1996 81 547-554.
51. Shi Y, Zou M, Ahring P, Al-Sedairy ST & Farid NR. Thyrotropin internalization is directed by a highly conserved motif in the seventh transmembrane region of its receptor. Endocrine 1995 3 409-414.
52. Gaudin P, Maoret JJ, Couvineau A, Rouyer-Fessard C & Laburthe M. Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors. Journal of Biological Chemistry 1998 273 4990-4996.